![David Canner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Canner
Director/Board Member at
INHIBIKASE THERAPEUTICS, INC.
Net worth: - $ as of 2026-06-29
Profile
David Canner is currently an Independent Director at Inhibikase Therapeutics, Inc. since 2024.
Dr. Canner is also a Partner at Soleus Capital LLC since 2018.
Dr. Canner holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-25 | 0 ( -.--% ) | - $ | 2026-06-29 |
David Canner active positions
| Companies | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 2024-10-20 |
Soleus Capital LLC | Corporate Officer/Principal | 2017-12-31 |
Training of David Canner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Soleus Capital LLC |
- Stock Market
- Insiders
- David Canner
